SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-14-004132
Filing Date
2014-04-24
Accepted
2014-04-24 16:34:39
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2219735z10-q.htm 10-Q 437883
2 EX-31.1 a2219735zex-31_1.htm EX-31.1 14129
3 EX-32.1 a2219735zex-32_1.htm EX-32.1 7755
10 G604248.JPG g604248.jpg GRAPHIC 15105
  Complete submission text file 0001047469-14-004132.txt   4129002

Data Files

Seq Description Document Type Size
4 EX-101.INS nutr-20140331.xml EX-101.INS 388183
5 EX-101.SCH nutr-20140331.xsd EX-101.SCH 46728
6 EX-101.CAL nutr-20140331_cal.xml EX-101.CAL 61120
7 EX-101.DEF nutr-20140331_def.xml EX-101.DEF 171669
8 EX-101.LAB nutr-20140331_lab.xml EX-101.LAB 871673
9 EX-101.PRE nutr-20140331_pre.xml EX-101.PRE 406892
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 14782099
SIC: 2833 Medicinal Chemicals & Botanical Products